Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

DERM

Journey Medical (DERM)

Journey Medical Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DERM
DateTimeSourceHeadlineSymbolCompany
09/09/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) ConferenceNASDAQ:DERMJourney Medical Corporation
09/04/20247:15AMGlobeNewswire Inc.Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:DERMJourney Medical Corporation
08/13/20243:05PMGlobeNewswire Inc.Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
08/12/20243:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
08/12/20243:01PMGlobeNewswire Inc.Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
08/06/20243:01PMGlobeNewswire Inc.Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024NASDAQ:DERMJourney Medical Corporation
08/01/20243:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
07/23/20243:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
07/12/20244:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
07/11/20243:05PMGlobeNewswire Inc.Journey Medical Corporation Appoints Michael C. Pearce to Board of DirectorsNASDAQ:DERMJourney Medical Corporation
07/10/20243:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
05/15/20243:01PMGlobeNewswire Inc.Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company ShowcaseNASDAQ:DERMJourney Medical Corporation
05/14/20243:46PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DERMJourney Medical Corporation
05/13/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
05/13/20243:01PMGlobeNewswire Inc.Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
05/07/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024NASDAQ:DERMJourney Medical Corporation
05/01/20243:01PMGlobeNewswire Inc.Journey Medical Corporation Appoints Joseph Benesch as Chief Financial OfficerNASDAQ:DERMJourney Medical Corporation
04/25/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024NASDAQ:DERMJourney Medical Corporation
03/21/20243:01PMGlobeNewswire Inc.Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:DERMJourney Medical Corporation
03/18/20247:30AMGlobeNewswire Inc.Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of RosaceaNASDAQ:DERMJourney Medical Corporation
03/15/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024NASDAQ:DERMJourney Medical Corporation
03/13/20247:30AMGlobeNewswire Inc.Journey Medical Corporation to Participate in the 36th Annual ROTH ConferenceNASDAQ:DERMJourney Medical Corporation
03/11/20247:30AMGlobeNewswire Inc.Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual MeetingNASDAQ:DERMJourney Medical Corporation
02/23/20244:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DERMJourney Medical Corporation
01/05/20247:30AMGlobeNewswire Inc.Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat RosaceaNASDAQ:DERMJourney Medical Corporation
01/02/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
01/02/20243:05PMGlobeNewswire Inc.Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 MillionNASDAQ:DERMJourney Medical Corporation
12/15/20233:46PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DERMJourney Medical Corporation
12/08/20234:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DERMJourney Medical Corporation
12/06/20237:00AMGlobeNewswire Inc.Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat RosaceaNASDAQ:DERMJourney Medical Corporation
 Showing the most relevant articles for your search:NASDAQ:DERM